摘要
目的:探讨前列腺汤治疗ⅢA型前列腺炎的疗效。方法:选择符合NIH诊断标准的ⅢA型前列腺炎患者46例,口服中药制剂前列腺汤,1剂/d,分2次口服,疗程30d。以NIH-CPSI评分和前列腺液(EPS)常规白细胞计数为指标,治疗前后进行疗效比较。结果:NIH-CPSI总评分治疗前后分别为(32.3±7.4)分和(17.8±4.2)分(P<0.01);疼痛或不适评分治疗前后分别为:(13.2±3.6)分和(7.8±2.3)分(P<0.01);排尿症状评分治疗前后分别为(4.5±1.2)分和(1.4±0.8)分(P<0.01);生活质量评分治疗前后分别为(14.6±7.4)分和(8.6±3.5)分(P<0.01);EPS中白细胞计数治疗前后分别为(20.6±2.4)个/HP和(5.6±3.2)个/HP。治愈8例,显效11例,有效20例,无效7例,总有效率84.78%。结论:前列腺汤治疗ⅢA型前列腺炎疗效较好。
Objective： To study the efficacy of Qianliexian Decoction in the treatment of National Institute of Health （ NIH ） ⅢA prostatitis. Methods： Forty-six patients with NIH IIIA prostatitis were treated by oral Qianliexian Decoction 1 dose and twice a day for 30 days. The results of the treatment were evaluated according to the NIH chronic prostatitis symptom index （ NIH-CPSI ） and. leukocyte counts in the expressed prostatic secretions （EPS）. Results ： The overall scores before and after the treatment were （ 32.3 ± 7.4） and （17.8 ± 4.2） on NIH-CPSI （P〈0.01）, （13.2 ± 3.6） and （7.8 ± 2.3） on pain or discomfort （P〈0.01）, （4.5 ± 1.2） and （1.4 ± 0.8） on urinary symptoms （P〈0.01）, （14.6 ± 7.4） and （8.6 ± 3.5） on the quality of life （P〈0.01）, and （ 20.6 ± 2.4） /HP and （5.6 ± 3.2） /HP on leukocyte counts, respectively. The decoction cured 8 of the patients and was shown to be obviously effective in 11 cases, effective in 20 and ineffective in 7, with a total efficacy rate of 84.78%. Conclusion ： Qianliexian Decoction is quite effective for the treatment of NIH IliA prostatitis.
出处
《中华男科学杂志》
CAS
CSCD
2007年第11期1044-1046,共3页
National Journal of Andrology
